Aprepitant
Brand name: Emend
Aprepitant comes in 15 pill versions in our database, in 4 strengths, from 6 manufacturers. Check the imprint to tell them apart.
Aprepitant pill images
40 mg 4 pills
-
G 583
Aprepitant 40 mg
White & yellow, capsule, 14 mm
Used for nausea and vomiting
- 464 40 mg Aprepitant 40 mg White & yellow, capsule, 14 mm Used for nausea and vomiting
- SZ 525 Aprepitant 40 mg White, capsule, 14 mm Used for nausea and vomiting
- 40mg Aprepitant 40 mg Yellow, capsule, 15 mm Used for nausea and vomiting
80 mg 5 pills
-
G 584
Aprepitant 80 mg
White, capsule, 18 mm
Used for nausea and vomiting
- 461 80 mg Aprepitant 80 mg White, capsule, 17 mm Used for nausea and vomiting
- SZ 528 Aprepitant 80 mg White, capsule, 18 mm Used for nausea and vomiting
- 80mg Aprepitant 80 mg White, capsule, 18 mm Used for nausea and vomiting
- No picture yet DIN 02298791 Aprepitant 80 mg Emend, Capsule, sold in Canada Used for nausea and vomiting
80 mg / 125 mg 1 pill
125 mg 5 pills
-
G 585
Aprepitant 125 mg
Pink & white, capsule, 19 mm
Used for nausea and vomiting
- 462 125 mg Aprepitant 125 mg Pink & white, capsule, 18 mm Used for nausea and vomiting
- SZ 529 Aprepitant 125 mg Blue & white, capsule, 19 mm Used for nausea and vomiting
- 125mg Aprepitant 125 mg Pink, capsule, 20 mm Used for nausea and vomiting
- No picture yet DIN 02298805 Aprepitant 125 mg Emend, Capsule, sold in Canada Used for nausea and vomiting
What is Aprepitant used for?
Aprepitant is used for nausea and vomiting.
- Medicine type
- Substance p/neurokinin-1 receptor antagonist
Official uses from the US prescribing label
Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)
EMEND, in combination with other antiemetic agents, is indicated for the:
- prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin
- prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).
Prevention of Postoperative Nausea and Vomiting (PONV)
EMEND is indicated for the prevention of postoperative nausea and vomiting.
Limitations of Use
EMEND has not been studied for the treatment of established nausea and vomiting.
Chronic continuous administration is not recommended.
From the FDA-approved label on DailyMed (published Apr 20, 2012).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.